MRD Testing: Primary Endpoint For Drug Development

MRD Testing: Primary Endpoint For Drug Development

User Photo
HMP CME

1 year
70 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center Discusses MRD Testing: Primary Endpoint For Drug Development at Lymphoma & Myeloma on October 18, 2018.
Up Next Autoplay